Robin Frey
20Patents
4h-index
60Co-inventors
62Inventor score
Filing activity: Mar 20, 2003 → Sep 16, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8940737B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Chemistry; Metallurgy | 7 | Active |
| US8426408B2 | Pyrimidine inhibitors of kinases | Human Necessities | 7 | Active |
| US7202363B2 | Thienopyridine and furopyridine kinase inhibitors | Emerging Cross-Sectional Technologies | 6 | Expired |
| US8975398B2 | NAMPT inhibitors | Chemistry; Metallurgy | 4 | Active |
| US7560552B2 | Thiopyrimidine and isothiazolopyrimidine kinase inhibitors | Chemistry; Metallurgy | 3 | Expired |
| US8889675B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Chemistry; Metallurgy | 3 | Active |
| US9227963B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Chemistry; Metallurgy | 2 | Active |
| US7737160B2 | Thienopyridine and furopyridine kinase inhibitors | Emerging Cross-Sectional Technologies | 2 | Active |
| US9266877B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Chemistry; Metallurgy | 2 | Active |
| US9844547B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Chemistry; Metallurgy | 1 | Active |
| US9187472B2 | NAMPT inhibitors | Chemistry; Metallurgy | 1 | Active |
| US9877958B2 | Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases | Chemistry; Metallurgy | 1 | Active |
| US8273736B2 | Thienopyridine and furopyridine kinase inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US9994581B2 | Bromodomain inhibitors | Chemistry; Metallurgy | 1 | Active |
| US7129260B2 | Isoindolinone kinase inhibitors | Chemistry; Metallurgy | 0 | Expired |
| US9193723B2 | NAMPT inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9796708B2 | Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors | Human Necessities | 0 | Active |
| US11786519B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Chemistry; Metallurgy | 0 | Active |
| US9328112B2 | Tetracyclic CDK9 kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8722890B2 | Thieno[3,2-C]pyridine kinase inhibitors with improved CYP safety profile | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.